No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:20200200-20211800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
2 |
chr2:20201800-20212400 |
Weak transcription |
Gastric |
stomach
|
3 |
chr2:20210000-20211600 |
Flanking Active TSS |
HepG2 |
liver
|
4 |
chr2:20210400-20212800 |
Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
5 |
chr2:20211200-20211600 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
6 |
chr2:20211200-20212000 |
Flanking Active TSS |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
7 |
chr2:20211400-20211600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
8 |
chr2:20211400-20211600 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
9 |
chr2:20211400-20211600 |
Bivalent/Poised TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
10 |
chr2:20211400-20211600 |
Bivalent Enhancer |
Primary T killer naive cells fromperipheralblood |
blood
|
11 |
chr2:20211400-20211600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
12 |
chr2:20211400-20211600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
13 |
chr2:20211400-20211800 |
Flanking Active TSS |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
14 |
chr2:20211400-20212000 |
Flanking Bivalent TSS/Enh |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
15 |
chr2:20211400-20212000 |
Flanking Active TSS |
A549 |
lung
|
16 |
chr2:20211400-20213200 |
Active TSS |
H9 Cell Line |
embryonic stem cell
|